Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Mission Therapeutics has signed a deal worth up to US$292 [...]

Fractyl Health has reported positive one-year data from the midpoint [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

Faeth Therapeutics has launched as a publicly traded oncology company [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

One-carbon Therapeutics has secured SEK 153 million (€13.9 million) in [...]

Scancell has reported updated results from its Phase 2 SCOPE [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]